These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
668 related articles for article (PubMed ID: 21346227)
1. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227 [TBL] [Abstract][Full Text] [Related]
2. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea. Lee JS; Oh M; ; Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438 [TBL] [Abstract][Full Text] [Related]
3. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715 [TBL] [Abstract][Full Text] [Related]
4. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study. John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944 [TBL] [Abstract][Full Text] [Related]
6. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215 [TBL] [Abstract][Full Text] [Related]
7. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis. Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982 [TBL] [Abstract][Full Text] [Related]
9. A Pooled Case-only Analysis of Reproductive Risk Factors and Breast Cancer Subtype Among Black Women in the Southeastern United States. Sanderson M; Pal T; Beeghly-Fadiel A; Fadden MK; Dujon SA; Clinton C; Jimenez C; Davis J; Fortune M; Thompson J; Benson K; Conley N; Reid S; Tezak A; Shu XO; Zheng W; Blot WJ; Lipworth L Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1416-1423. PubMed ID: 33947654 [TBL] [Abstract][Full Text] [Related]
10. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study. Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260 [TBL] [Abstract][Full Text] [Related]
11. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study. Figueroa JD; Davis Lynn BC; Edusei L; Titiloye N; Adjei E; Clegg-Lamptey JN; Yarney J; Wiafe-Addai B; Awuah B; Duggan MA; Wiafe S; Nyarko K; Aitpillah F; Ansong D; Hewitt SM; Ahearn T; Garcia-Closas M; Brinton LA; Int J Cancer; 2020 Sep; 147(6):1535-1547. PubMed ID: 32068253 [TBL] [Abstract][Full Text] [Related]
12. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Ma H; Wang Y; Sullivan-Halley J; Weiss L; Marchbanks PA; Spirtas R; Ursin G; Burkman RT; Simon MS; Malone KE; Strom BL; McDonald JA; Press MF; Bernstein L Cancer Res; 2010 Jan; 70(2):575-87. PubMed ID: 20068186 [TBL] [Abstract][Full Text] [Related]
13. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women. Chen L; Li CI; Tang MT; Porter P; Hill DA; Wiggins CL; Cook LS Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1297-304. PubMed ID: 27307466 [TBL] [Abstract][Full Text] [Related]
14. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. Yang XR; Chang-Claude J; Goode EL; Couch FJ; Nevanlinna H; Milne RL; Gaudet M; Schmidt MK; Broeks A; Cox A; Fasching PA; Hein R; Spurdle AB; Blows F; Driver K; Flesch-Janys D; Heinz J; Sinn P; Vrieling A; Heikkinen T; Aittomäki K; Heikkilä P; Blomqvist C; Lissowska J; Peplonska B; Chanock S; Figueroa J; Brinton L; Hall P; Czene K; Humphreys K; Darabi H; Liu J; Van 't Veer LJ; van Leeuwen FE; Andrulis IL; Glendon G; Knight JA; Mulligan AM; O'Malley FP; Weerasooriya N; John EM; Beckmann MW; Hartmann A; Weihbrecht SB; Wachter DL; Jud SM; Loehberg CR; Baglietto L; English DR; Giles GG; McLean CA; Severi G; Lambrechts D; Vandorpe T; Weltens C; Paridaens R; Smeets A; Neven P; Wildiers H; Wang X; Olson JE; Cafourek V; Fredericksen Z; Kosel M; Vachon C; Cramp HE; Connley D; Cross SS; Balasubramanian SP; Reed MW; Dörk T; Bremer M; Meyer A; Karstens JH; Ay A; Park-Simon TW; Hillemanns P; Arias Pérez JI; Menéndez Rodríguez P; Zamora P; Benítez J; Ko YD; Fischer HP; Hamann U; Pesch B; Brüning T; Justenhoven C; Brauch H; Eccles DM; Tapper WJ; Gerty SM; Sawyer EJ; Tomlinson IP; Jones A; Kerin M; Miller N; McInerney N; Anton-Culver H; Ziogas A; Shen CY; Hsiung CN; Wu PE; Yang SL; Yu JC; Chen ST; Hsu GC; Haiman CA; Henderson BE; Le Marchand L; Kolonel LN; Lindblom A; Margolin S; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Górski B; Gronwald J; Hooning MJ; Hollestelle A; van den Ouweland AM; Jager A; Kriege M; Tilanus-Linthorst MM; Collée M; Wang-Gohrke S; Pylkäs K; Jukkola-Vuorinen A; Mononen K; Grip M; Hirvikoski P; Winqvist R; Mannermaa A; Kosma VM; Kauppinen J; Kataja V; Auvinen P; Soini Y; Sironen R; Bojesen SE; Ørsted DD; Kaur-Knudsen D; Flyger H; Nordestgaard BG; Holland H; Chenevix-Trench G; Manoukian S; Barile M; Radice P; Hankinson SE; Hunter DJ; Tamimi R; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gaborieau V; Devilee P; Huijts PE; Tollenaar RA; Seynaeve C; Dite GS; Apicella C; Hopper JL; Hammet F; Tsimiklis H; Smith LD; Southey MC; Humphreys MK; Easton D; Pharoah P; Sherman ME; Garcia-Closas M J Natl Cancer Inst; 2011 Feb; 103(3):250-63. PubMed ID: 21191117 [TBL] [Abstract][Full Text] [Related]
15. Aspirin use and risk of breast cancer in African American women. Bertrand KA; Bethea TN; Gerlovin H; Coogan PF; Barber L; Rosenberg L; Palmer JR Breast Cancer Res; 2020 Sep; 22(1):96. PubMed ID: 32887656 [TBL] [Abstract][Full Text] [Related]
16. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI Cancer Causes Control; 2011 Mar; 22(3):399-405. PubMed ID: 21184265 [TBL] [Abstract][Full Text] [Related]
17. Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women. Ambrosone CB; Zirpoli G; Hong CC; Yao S; Troester MA; Bandera EV; Schedin P; Bethea TN; Borges V; Park SY; Chandra D; Rosenberg L; Kolonel LN; Olshan AF; Palmer JR J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26085483 [TBL] [Abstract][Full Text] [Related]
18. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study. Ambrosone CB; Zirpoli G; Ruszczyk M; Shankar J; Hong CC; McIlwain D; Roberts M; Yao S; McCann SE; Ciupak G; Hwang H; Khoury T; Jandorf L; Bovbjerg DH; Pawlish K; Bandera EV Cancer Causes Control; 2014 Feb; 25(2):259-65. PubMed ID: 24249438 [TBL] [Abstract][Full Text] [Related]
19. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Li CI; Beaber EF; Tang MT; Porter PL; Daling JR; Malone KE Breast Cancer Res Treat; 2013 Jan; 137(2):579-87. PubMed ID: 23224237 [TBL] [Abstract][Full Text] [Related]
20. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]